Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melrose

Showing results (501-510 of 539) with videos related to

Pageof 54
Sort By:
Genome Biology|October 3, 2022
H3K18 lactylation marks tissue-specific active enhancersEva Galle, Chee-Wai Wong, Adhideb Ghosh, et al.
Parasites & Vectors|January 15, 2013
Lymphatic filariasis in Papua New Guinea: distribution at district level and impact of mass drug administration, 1980 to 2011Patricia M Graves, Leo Makita, Melinda Susapu, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2006
Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalinMark J Field, Peter J Cox, Emma Stott, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 4, 2013
Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trialWilliam B Armstrong, Thomas H Taylor, Ann R Kennedy, et al.
Neurogenetics|January 17, 2007
Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's diseaseJulie P Taylor, Mary M Hulihan, Jennifer M Kachergus, et al.
The Biochemical Journal|April 9, 2013
Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodiesPaul Davies, Kelly M Hinkle, Nour N Sukar, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 2025
Pharmacological effects of small molecule BCR-ABL tyrosine kinase inhibitors on platelet functionYiheng Zhang, Chih-Jen Yang, Alexander R Melrose, et al.
Elife|September 21, 2017
Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in miceMattia Volta, Dayne A Beccano-Kelly, Sarah A Paschall, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 8, 2024
<b>Pharmacological effects of small molecule BCR-ABL tyrosine kinase inhibitors on platelet </b>Yiheng Zhang, Chih-Jen Yang, Alexander R Melrose, et al.
Platelets|April 3, 2020
The basement membrane protein nidogen-1 supports platelet adhesion and activationHari Hara Sudhan Lakshmanan, Alexander R Melrose, Anna-Liisa I Sepp, et al.
Pageof 54

Showing results (501-510 of 539) with videos related to

Sort By:
Pageof 54
Genome Biology|October 3, 2022
H3K18 lactylation marks tissue-specific active enhancersEva Galle, Chee-Wai Wong, Adhideb Ghosh, et al.
Parasites & Vectors|January 15, 2013
Lymphatic filariasis in Papua New Guinea: distribution at district level and impact of mass drug administration, 1980 to 2011Patricia M Graves, Leo Makita, Melinda Susapu, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2006
Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalinMark J Field, Peter J Cox, Emma Stott, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 4, 2013
Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trialWilliam B Armstrong, Thomas H Taylor, Ann R Kennedy, et al.
Neurogenetics|January 17, 2007
Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's diseaseJulie P Taylor, Mary M Hulihan, Jennifer M Kachergus, et al.
The Biochemical Journal|April 9, 2013
Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodiesPaul Davies, Kelly M Hinkle, Nour N Sukar, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 2025
Pharmacological effects of small molecule BCR-ABL tyrosine kinase inhibitors on platelet functionYiheng Zhang, Chih-Jen Yang, Alexander R Melrose, et al.
Elife|September 21, 2017
Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in miceMattia Volta, Dayne A Beccano-Kelly, Sarah A Paschall, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 8, 2024
<b>Pharmacological effects of small molecule BCR-ABL tyrosine kinase inhibitors on platelet </b>Yiheng Zhang, Chih-Jen Yang, Alexander R Melrose, et al.
Platelets|April 3, 2020
The basement membrane protein nidogen-1 supports platelet adhesion and activationHari Hara Sudhan Lakshmanan, Alexander R Melrose, Anna-Liisa I Sepp, et al.
Pageof 54